US Broker Ratings

Neurogene Inc. (NGNE) Investor Outlook: Potential Upside of 118.56% with Strong Buy Ratings

Neurogene Inc. (NASDAQ: NGNE), a clinical-stage biotechnology company, is making waves in the healthcare sector with its focus on developing genetic medicines for rare neurological diseases. Headquartered in New York..

Kingsoft Cloud Holdings Limited (KC) Stock Analysis: Unpacking the 25% Potential Upside

For investors eyeing opportunities in the technology sector, Kingsoft Cloud Holdings Limited (NASDAQ: KC) presents an intriguing proposition with a potential upside of 25.16%, according to analyst ratings. Despite its..

SmartRent, Inc. (SMRT) Stock Analysis: Evaluating a 60% Potential Upside in the Tech Sector

SmartRent, Inc. (NASDAQ: SMRT) is gaining attention in the technology sector, specifically within the software application industry. As a provider of innovative real estate technology solutions, SmartRent is known for..

Zhengye Biotechnology Holding L (ZYBT) Stock Analysis: Navigating a $265 Million Market Cap in Veterinary Vaccines

Zhengye Biotechnology Holding L (ZYBT) presents a unique opportunity in the healthcare sector, particularly in the niche industry of veterinary vaccines. With a market capitalization of $265.39 million, Zhengye Biotechnology..

iTeos Therapeutics, Inc. (ITOS) Stock Analysis: Navigating a Promising Pipeline with a 5.11% Potential Upside

iTeos Therapeutics, Inc. (NASDAQ: ITOS) sits at the intersection of biotechnology and innovation, offering a compelling proposition for investors with its focus on pioneering immuno-oncology therapeutics. Headquartered in Watertown, Massachusetts,..

Asure Software Inc (ASUR) Stock Analysis: Unveiling a 48% Potential Upside for Investors

Asure Software Inc (NASDAQ: ASUR), a key player in the technology sector, is gaining attention for its promising potential upside. With its headquarters nestled in Austin, Texas, Asure Software specializes..

Cytek Biosciences, Inc. (CTKB) Stock Analysis: A 61.97% Potential Upside Worth Watching

Cytek Biosciences, Inc. (NASDAQ: CTKB) stands as a noteworthy player in the healthcare sector, specifically within the medical devices industry. Headquartered in Fremont, California, Cytek Biosciences is renowned for its..

Uber Technologies, Inc. (UBER) Stock Analysis: Riding High with a 14.72% Potential Upside

For investors with a keen eye on the technology sector, Uber Technologies, Inc. (NYSE: UBER) presents a compelling opportunity as it continues to make significant strides in the global market...

Triller Group Inc. (ILLR) Stock Analysis: Can This Tech Underdog Overcome Its Financial Hurdles?

Triller Group Inc. (ILLR) is navigating the competitive landscape of the technology sector, specifically within the software application industry. With a market capitalization of $90.18 million, this Los Angeles-based company..

Tvardi Therapeutics, Inc. (TVRD): Investor Outlook on Its 119.65% Potential Upside

Tvardi Therapeutics, Inc. (NASDAQ: TVRD) is making waves in the biotechnology sector with its promising pipeline of small molecule therapies. The clinical-stage biopharmaceutical company, headquartered in Sugar Land, Texas, is..

Freshworks Inc. (FRSH) Investor Outlook: Impressive 52.49% Potential Upside Amid Strong Buy Ratings

Freshworks Inc. (NASDAQ: FRSH), a prominent player in the technology sector, is capturing the attention of investors with its impressive potential upside of 52.49%, according to analyst ratings. This software-as-a-service..

Docebo Inc. (DCBO) Stock Analysis: Growth Potential with 28% Upside for Tech-Savvy Investors

For investors with an eye on the technology sector, Docebo Inc. (NASDAQ: DCBO) presents a compelling opportunity. As a leading player in the software-application industry, Docebo is gaining attention for..

Blend Labs, Inc. (BLND) Investor Outlook: Unveiling a 49% Potential Upside in the Fintech Market

Blend Labs, Inc. (NYSE: BLND) is standing out as a compelling prospect for investors focused on the intersection of technology and financial services. With a market capitalization of approximately $868.64..

Asana, Inc. (ASAN) Stock Analysis: Unveiling the 6.95% Potential Upside in a Competitive Software Market

Asana, Inc. (NYSE: ASAN), a prominent player in the technology sector, stands out with its innovative work management software platform. Currently trading at $15.35, Asana’s stock reflects a modest price..

aTyr Pharma, Inc. (ATYR) Stock Analysis: Potential 291.70% Upside in Biotech Innovation

aTyr Pharma, Inc. (NASDAQ: ATYR) represents a compelling opportunity within the biotechnology sector, particularly due to its innovative focus on translating tRNA synthetase biology into therapeutic solutions. Headquartered in San..

Sprinklr, Inc. (CXM) Stock Analysis: Exploring a 20% Upside Potential Amidst Strong Revenue Growth

Sprinklr, Inc. (NYSE: CXM) is steadily carving out its niche in the competitive technology sector, particularly within the software application industry. With a market capitalization of $2.35 billion, this New..

Candel Therapeutics, Inc. (CADL): Investor Outlook on a Biotech Stock with 219% Upside Potential

As interest in the biotechnology sector continues to surge, Candel Therapeutics, Inc. (NASDAQ: CADL) stands out as a potential high-reward opportunity for investors seeking exposure to clinical-stage biopharmaceutical advancements. With..

Immutep Limited (IMMP) Stock Analysis: Unveiling a 436% Potential Upside Amidst Biotech Innovations

Immutep Limited (NASDAQ: IMMP), a Sydney-based biotechnology company, is making waves in the healthcare sector with its innovative approach to immunotherapy. Specializing in LAG-3 related therapies for cancer and autoimmune..

Vanda Pharmaceuticals (VNDA) Stock Analysis: Exploring a Potential 171% Upside for Investors

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA), a biopharmaceutical company headquartered in Washington, D.C., is capturing investor attention with its impressive potential upside of 171.23%. Operating within the healthcare sector and biotechnology..

Sportradar Group AG (SRAD) Stock Analysis: Navigating Growth with 17.1% Revenue Surge

Sportradar Group AG (NASDAQ: SRAD), a leader in the sports data services sector, has been making waves with its impressive revenue growth and strategic positioning in the technology industry. Headquartered..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds